These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 20554330

  • 1. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.
    Venken K, Hellings N, Hensen K, Rummens JL, Stinissen P.
    J Neuroimmunol; 2010 Sep 14; 226(1-2):185-91. PubMed ID: 20554330
    [Abstract] [Full Text] [Related]

  • 2. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, Flechter S, Abramsky O, Milo R, Karni A, Ben-Nun A.
    Eur J Immunol; 1997 Nov 14; 27(11):3059-69. PubMed ID: 9394837
    [Abstract] [Full Text] [Related]

  • 3. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P.
    J Neurosci Res; 2001 Feb 01; 63(3):290-302. PubMed ID: 11170179
    [Abstract] [Full Text] [Related]

  • 4. T-cell responses to neurofilament light protein are part of the normal immune repertoire.
    Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S.
    Int Immunol; 2009 Apr 01; 21(4):433-41. PubMed ID: 19240089
    [Abstract] [Full Text] [Related]

  • 5. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ, Krakauer M, Bendtzen K, Sørensen PS, Sellebjerg F, Nielsen CH.
    Clin Immunol; 2008 Oct 01; 129(1):80-9. PubMed ID: 18653385
    [Abstract] [Full Text] [Related]

  • 6. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
    Kaushansky N, Eisenstein M, Zilkha-Falb R, Ben-Nun A.
    Autoimmun Rev; 2010 Feb 01; 9(4):233-6. PubMed ID: 19683076
    [Abstract] [Full Text] [Related]

  • 7. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
    de Rosbo NK, Ben-Nun A.
    J Autoimmun; 1998 Aug 01; 11(4):287-99. PubMed ID: 9776706
    [Abstract] [Full Text] [Related]

  • 8. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis.
    Burns J, Bartholomew B, Lobo S.
    Ann Neurol; 1999 Jan 01; 45(1):33-9. PubMed ID: 9894874
    [Abstract] [Full Text] [Related]

  • 9. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    Sarchielli P, Di Filippo M, Candeliere A, Chiasserini D, Mattioni A, Tenaglia S, Bonucci M, Calabresi P.
    J Neuroimmunol; 2007 Aug 01; 188(1-2):146-58. PubMed ID: 17628700
    [Abstract] [Full Text] [Related]

  • 10. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G, Stinissen P, Hauben L, Van den Berg-Loonen E, Raus J, Zhang J.
    Ann Neurol; 1997 Jul 01; 42(1):18-27. PubMed ID: 9225681
    [Abstract] [Full Text] [Related]

  • 11. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M, Oschmann P, Engel R, Weishaupt A, van Noort JM, Jomaa H, Eberl M.
    Immunology; 2007 May 01; 121(1):29-39. PubMed ID: 17239199
    [Abstract] [Full Text] [Related]

  • 12. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L, Laplaud DA, Pettré S, Ballet C, Michel L, Hillion S, Braudeau C, Connan F, Lefrère F, Wiertlewski S, Guillet JG, Brouard S, Choppin J, Soulillou JP.
    Eur J Immunol; 2008 Jul 01; 38(7):1889-99. PubMed ID: 18506883
    [Abstract] [Full Text] [Related]

  • 13. A CFSE based assay for measuring CD4+CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses.
    Venken K, Thewissen M, Hellings N, Somers V, Hensen K, Rummens JL, Stinissen P.
    J Immunol Methods; 2007 Apr 30; 322(1-2):1-11. PubMed ID: 17368474
    [Abstract] [Full Text] [Related]

  • 14. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N, Mendel I, Ben-Nun A.
    Eur J Immunol; 1995 Apr 30; 25(4):985-93. PubMed ID: 7737302
    [Abstract] [Full Text] [Related]

  • 15. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA, Bourque CR, Devaux B, Olson CD, Sunshine GH, Hirani S, Wallner BP, Smilek DE, Happ MP.
    J Immunol; 1998 Jul 01; 161(1):504-12. PubMed ID: 9647262
    [Abstract] [Full Text] [Related]

  • 16. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K, Aranami T, Endoh M, Miyake S, Yamamura T.
    Brain; 2004 Sep 01; 127(Pt 9):1917-27. PubMed ID: 15229129
    [Abstract] [Full Text] [Related]

  • 17. Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis.
    Hafler DA, Benjamin DS, Burks J, Weiner HL.
    J Immunol; 1987 Jul 01; 139(1):68-72. PubMed ID: 2438352
    [Abstract] [Full Text] [Related]

  • 18. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP, Jones RE, Rich C, Dahan R, Link J, David CS, Chou YK, Offner H, Vandenbark AA.
    J Neurosci Res; 2004 Oct 01; 78(1):100-14. PubMed ID: 15372502
    [Abstract] [Full Text] [Related]

  • 19. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G, Denzer U, Lohse A, Raus J, Stinissen P.
    J Autoimmun; 1999 Sep 01; 13(2):233-46. PubMed ID: 10479392
    [Abstract] [Full Text] [Related]

  • 20. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
    Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, Linington C, Diener P.
    J Immunol; 1991 Mar 01; 146(5):1490-5. PubMed ID: 1899688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.